全文获取类型
收费全文 | 1240篇 |
免费 | 64篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 13篇 |
儿科学 | 12篇 |
妇产科学 | 36篇 |
基础医学 | 171篇 |
口腔科学 | 22篇 |
临床医学 | 94篇 |
内科学 | 200篇 |
皮肤病学 | 44篇 |
神经病学 | 153篇 |
特种医学 | 127篇 |
外科学 | 208篇 |
综合类 | 9篇 |
预防医学 | 59篇 |
眼科学 | 17篇 |
药学 | 73篇 |
中国医学 | 5篇 |
肿瘤学 | 69篇 |
出版年
2023年 | 7篇 |
2022年 | 28篇 |
2021年 | 54篇 |
2020年 | 29篇 |
2019年 | 43篇 |
2018年 | 41篇 |
2017年 | 22篇 |
2016年 | 40篇 |
2015年 | 60篇 |
2014年 | 57篇 |
2013年 | 76篇 |
2012年 | 114篇 |
2011年 | 130篇 |
2010年 | 83篇 |
2009年 | 44篇 |
2008年 | 74篇 |
2007年 | 80篇 |
2006年 | 70篇 |
2005年 | 68篇 |
2004年 | 57篇 |
2003年 | 35篇 |
2002年 | 30篇 |
2001年 | 6篇 |
2000年 | 1篇 |
1999年 | 4篇 |
1998年 | 7篇 |
1997年 | 7篇 |
1996年 | 10篇 |
1995年 | 2篇 |
1994年 | 5篇 |
1993年 | 3篇 |
1992年 | 1篇 |
1990年 | 1篇 |
1989年 | 2篇 |
1988年 | 3篇 |
1987年 | 1篇 |
1985年 | 3篇 |
1983年 | 4篇 |
1982年 | 1篇 |
1981年 | 2篇 |
1979年 | 1篇 |
1973年 | 1篇 |
1966年 | 1篇 |
1965年 | 3篇 |
1961年 | 1篇 |
排序方式: 共有1312条查询结果,搜索用时 31 毫秒
21.
Katarina K. Jovanović Aleksandar G. Savić Radmila Janković Siniša Radulović Sladjana Z. Spasić Ksenija Radotić 《Medical hypotheses》2013
The key method for therapies of various cancer types could be the molecular-targeted therapy, based on individual gene profile for each patient. One of the main procedures used for genetic testing is the real-time polymerase chain reaction (real-time PCR). 相似文献
22.
Thomas Klopstock MD Aleksandar Videnovic MD Almut Turid Bischoff MD Cecilia Bonnet MD Laura Cif MD Cynthia Comella MD Marta Correa-Vela MD Maria L. Escolar MD Jamie L. Fraser MD Victoria Gonzalez MD Neal Hermanowicz MD Robert Jech MD Hyder A. Jinnah MD Tomasz Kmiec MD Anthony Lang MD Maria J. Martí MD Saadet Mercimek-Andrews MD Migvis Monduy MD Graeme A.M. Nimmo MBBS Belen Perez-Dueñas MD Helle Cecilie Viekilde Pfeiffer MD Lluis Planellas MD Emmanuel Roze MD Nivedita Thakur MD Laura Tochen MD Nora Vanegas-Arroyave MD Giovanna Zorzi MD Colleen Burns PhD Feriandas Greblikas MD 《Movement disorders》2021,36(6):1342-1352
23.
Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof-of-Concept Trial
24.
25.
26.
Commitment toward the natural T (iNKT) cell lineage occurs at the CD4+8+ stage of thymic ontogeny 下载免费PDF全文
Bezbradica JS Hill T Stanic AK Van Kaer L Joyce S 《Proceedings of the National Academy of Sciences of the United States of America》2005,102(14):5114-5119
T lineage commitment occurs in a discrete, stage-specific manner during thymic ontogeny. Intrathymic precursor transfer experiments and the identification of CD4(+)8+ double-positive (DP), V alpha 14J alpha 18 natural T (iNKT) cells suggest that commitment to this lineage might occur at the DP stage. Nevertheless, this matter remains contentious because others failed to detect V alpha 14J alpha 18-positive iNKT cells that are CD4(+)8+. In resolution to this issue, we demonstrate that retinoic acid receptor-related orphan receptor gamma (ROR gamma)0/0 thymi, which accumulate immature single-positive (ISP) thymocytes that precede the DP stage, do not rearrange V alpha 14-to-J alpha 18 gene segments, suggesting that this event occurs at a post-ISP stage. Mixed radiation bone marrow chimeras revealed that RORgamma functions in an iNKT cell lineage-specific manner. Further, introgression of a Bcl-x(L) transgene into ROR gamma(0/0) mice, which promotes survival and permits secondary rearrangements of distal V alpha and J alpha gene segments at the DP stage, rescues V alpha 14-to-J alpha 18 recombination. Similarly, introgression of a rearranged V alpha 14J alpha 18 transgene into ROR gamma(0/0) mice results in functional iNKT cells. Thus, our data support the "T cell receptor-instructive (mainstream precursor) model" of iNKT cell lineage specification where V alpha 14-to-J alpha 18 rearrangement, positive selection, and iNKT cell lineage commitment occur at or after the DP stage of ontogeny. 相似文献
27.
Marijana Kosani Branislav Rankovi Aleksandar Ran
i Tatjana Stanojkovi 《Yao wu shi pin fen xi = Journal of food and drug analysis.》2016,24(3):477
This study is designed for the determination of metal concentrations, antioxidant, antimicrobial, and anticancer potential of two edible mushrooms Lactarius deliciosus and Macrolepiota procera. Concentrations of nine metals are determined and all metals are present in the allowable concentrations in the tested mushrooms except Cd in M. procera. Antioxidant activity was evaluated by free radical scavenging and reducing power. M. procera extract had more potent free radical scavenging activity (IC50 = 311.40 μg/mL) than L. deliciosus extract. Moreover, the tested extracts had effective reducing power. The total content of phenol in the extracts was examined using Folin–Ciocalteu reagent and obtained values expressed as pyrocatechol equivalents. Further, the antimicrobial potential was determined with a microdilution method on 15 microorganisms. Among the tested species, extract of L. deliciosus showed a better antimicrobial activity with minimum inhibitory concentration values ranging from 2.5 mg/mL to 20 mg/mL. Finally, the cytotoxic activity was tested using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide method on human epithelial carcinoma HeLa cells, human lung carcinoma A549 cells, and human colon carcinoma LS174 cells. Extract of both mushrooms expressed similar cytotoxic activity with IC50 values ranging from 19.01 μg/mL to 80.27 μg/mL. 相似文献
28.
Ivana Skrinjar Vlaho Brailo Danica Vidovic-Juras Vanja Vucicevic-Boras Aleksandar Milenovic 《Medicina oral, patología oral y cirugía bucal》2015,20(4):e402-e407
Background
Oral squamous cell carcinoma (OSCC) constitutes 3 percent of all cancers with predominant occurrence in middle aged and elderly males. Tumour recurrence worsens disease prognosis and decreases quality of life in patients with OSCC. Proinflammatory cytokines such as interleukin-6 (IL-6) and tumour necrosis factor alpha (TNF-α) have been suggested to play a certain role in variety of tumours. The aim of this study was to investigate the relationship of pretreatment serum IL-6 and TNF-α levels on tumour recurrence in patients with OSCC in order to identify potential biomarkers for the early detection of disease recurrence.Material and Methods
The patients with newly diagnosed OSCC were treated and followed from the first visit from November 2006 until January 2008. Serum IL-6 and TNF-α concentrations were measured. The records of the patients were re-examined in July 2012 and data were recorded about cancer characteristics and tumour recurrence. Disease free survival was analyzed by Kaplan-Meier survival curves, log rank test and Cox proportional hazards regression.Results
Serum IL-6 was shown as an independent risk factor for tumour recurrence.Conclusions
Pretreatment serum IL-6 concentration may be a useful biomarker for identification of OSCC patients with increased risk of the disease recurrence. Key words: Serum IL-6, serum TNF-α, oral cancer, recurrence. 相似文献29.
30.